9:22 AM
Leo Group India
| ||
| GoM on pharma meets drug makers The Hindu The Group of Ministers (GoM) headed by Agriculture Minister, Sharad Pawar to formulate a comprehensive pharmaceutical policy aimed at making essential drugs more affordable to the common man met on Monday, some leading lights of the pharmaceutical ... See all stories on this topic » | ||
| Stellar Pharmaceuticals Inc. Secures US$6.0 Million Term Loan to Support ... MarketWatch (press release) MILTON, ONTARIO, May 14, 2012 (MARKETWIRE via COMTEX) -- Stellar Pharmaceuticals Inc. ("Stellar" or the "Company") (otcqb:SLXCF) (OTN:SLXCF) (pinksheets:SLXCF) today announced the closing of the first of two tranches of a US$6.0 million term loan from ... See all stories on this topic » | ||
| Raptor Pharmaceutical Added to NASDAQ Biotechnology Index MarketWatch (press release) NOVATO, Calif., May 14, 2012 (GlobeNewswire via COMTEX) -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (NASDAQ:RPTP) , announced that NASDAQ is adding Raptor to the NASDAQ Biotechnology Index . The NBI includes seasoned NASDAQ Global Market ... See all stories on this topic » | ||
| Leading Specialty Pharmaceutical Company to Implement Ross Enterprise MarketWatch (press release) ATLANTA, May 14, 2012 (BUSINESS WIRE) -- CDC Software, an enterprise software provider of on-premise and cloud technologies, today announced that Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, plans to implement Ross Enterprise ... See all stories on this topic » | ||
| ||
| Ministers' panel on pharma to meet again on Friday Hindu Business Line A Group of Ministers (GoM) on National Pharmaceutical Pricing Policy is likely to meet again on Friday. The GoM, which met on Monday, decided to meet again to hear out stakeholders before starting internal deliberations from June. See all stories on this topic » | ||
| FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops ... MarketWatch (press release) NEW YORK, NY, May 14, 2012 (MARKETWIRE via COMTEX) -- Ohr Pharmaceutical Inc. (OBB:OHRP) announced today that its Squalamine Eye Drops, a potent inhibitor of multiple growth factors implicated in angiogenesis, has been awarded Fast Track designation by ... See all stories on this topic » | ||
| Semi-Annual Changes to the NASDAQ Biotechnology Index MarketWatch (press release) The Index is designed to track the performance of a set of NASDAQ-listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is re-ranked ... See all stories on this topic » | ||
| Arena Pharmaceutical's Recent Spike Offers Income Opportunity Seeking Alpha Arena Pharmaceuticals (ARNA) shot up 73.4% Friday anticipating the FDA Advisory Committee's vote in favor of Lorcaserin's benefit / risk profile for weight management. The potential profits for Arena Pharmaceuticals are incredible considering an ... See all stories on this topic » | ||
| China orders strict checks on capsules China Daily The State Food and Drug Administration (SFDA) said in a statement on its website that reports by local authorities have shown that some pharmaceutical makers lack the knowledge or equipment to carry out in-house testing on pharmaceutical gelatin, ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment